CEO, Third Pole Therapeutics
Bill leads Third Pole, bringing over 25 years of experience creating profitable organizations within the pharma, life sciences, medical device, molecular diagnostics and healthcare software markets on a global basis. Most recently, Athenson served as CEO of Three Lakes Partners, conducting impact funding of pioneering drug discovery, diagnostics and medical device-based technologies and collaborations focused on accelerating therapies and improving care for patients living with Pulmonary Fibrosis.
Bill has served on the Board of the Open Source Imaging Consortium, with the goal of leveraging AI to create an imaging biomarker that accurately detects fibrotic disease progression in the lungs.
He has extensive experience in building and leading high performing cross functional device development, operations, and commercial groups from product concept through commercial execution across U.S., Europe, and Asia, with American Hospital Supply, Baxter Healthcare, Allegiance Healthcare and Cardinal Health.
Bill received his MBA from the Kellogg School of Management at Northwestern University and a Bachelor of Science degree from Fordham University in New York.